Orion Oyj (HEL:ORNBV) Could Easily Take On More Debt
Mar 20
Finnish (OMX) Healthcare Sector Analysis
UpdatedMar 24, 2023
DataAggregated Company Financials
Companies15
- 7D-3.8%
- 3M-17.0%
- 1Y-12.4%
- YTD-15.2%
Over the last 7 days, the Healthcare industry has dropped 1.6%, driven by Orion Oyj declining 1.8%. On the other hand Optomed Oyj is actually up 13%. Overall the industry is down 10% in 12 months. As for the next few years, earnings are expected to grow by 12% per annum.
Sector Valuation and Performance
Has the Finnish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 25 Mar 2023 | €8.7b | €5.0b | €335.5m | 35.5x | 25.8x | 1.7x |
| Mon, 20 Feb 2023 | €9.5b | €5.0b | €335.6m | 38.7x | 28.4x | 1.9x |
| Wed, 18 Jan 2023 | €10.1b | €5.3b | €373.8m | 20x | 27x | 1.9x |
| Fri, 16 Dec 2022 | €10.0b | €5.3b | €373.8m | 18.5x | 26.8x | 1.9x |
| Sun, 13 Nov 2022 | €9.7b | €5.3b | €384.8m | 18.7x | 25.1x | 1.8x |
| Tue, 11 Oct 2022 | €9.1b | €5.0b | €282.1m | 17.1x | 32.4x | 1.8x |
| Thu, 08 Sep 2022 | €9.9b | €5.0b | €284.2m | 18.1x | 34.7x | 2x |
| Sat, 06 Aug 2022 | €10.5b | €5.0b | €288.2m | 20.2x | 36.5x | 2.1x |
| Mon, 04 Jul 2022 | €9.9b | €4.9b | €277.1m | 26x | 35.6x | 2x |
| Wed, 01 Jun 2022 | €9.5b | €4.9b | €277.1m | 28x | 34.3x | 1.9x |
| Fri, 29 Apr 2022 | €9.6b | €4.8b | €275.7m | 27.6x | 34.9x | 2x |
| Sun, 27 Mar 2022 | €9.8b | €4.8b | €280.7m | 29.1x | 34.8x | 2x |
| Tue, 22 Feb 2022 | €10.6b | €4.8b | €281.5m | 32.6x | 37.6x | 2.2x |
| Thu, 20 Jan 2022 | €9.9b | €4.6b | €269.9m | 27.2x | 36.8x | 2.1x |
| Sat, 18 Dec 2021 | €10.0b | €4.6b | €269.9m | 26.9x | 37.1x | 2.2x |
| Mon, 15 Nov 2021 | €10.6b | €4.6b | €270.3m | 28.7x | 39.3x | 2.3x |
| Wed, 13 Oct 2021 | €10.0b | €4.6b | €271.3m | 26.1x | 36.8x | 2.2x |
| Fri, 10 Sep 2021 | €9.7b | €4.6b | €271.3m | 25.2x | 35.7x | 2.1x |
| Sun, 08 Aug 2021 | €9.8b | €4.6b | €277.8m | 25.6x | 35.2x | 2.1x |
| Sat, 01 May 2021 | €10.0b | €4.5b | €268.8m | 24.9x | 37.2x | 2.2x |
| Tue, 02 Feb 2021 | €9.3b | €4.5b | €261.3m | 29.4x | 35.5x | 2.1x |
| Fri, 06 Nov 2020 | €8.3b | €4.4b | €270.8m | 31.1x | 30.7x | 1.9x |
| Mon, 10 Aug 2020 | €8.2b | €4.5b | €279.2m | 66x | 29.4x | 1.8x |
| Sun, 03 May 2020 | €9.3b | €4.5b | €278.4m | 33.6x | 33.3x | 2.1x |
Price to Earnings Ratio
27.5x
Current Industry PE
- Investors are pessimistic on the Finnish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 26.4x which is lower than its 3-year average PE of 33.4x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 6.4% per year over the last three years.
- Revenues for these companies have grown 3.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare sector?
| FI Market | 0.39% | |
| Healthcare | -3.80% | |
| Healthtech | 4.61% | |
| Medical Equipment | 0.14% | |
| Healthcare Services | -1.38% | |
| Pharma | -5.12% | |
| Biotech | -5.61% | |
| Life Sciences | -8.22% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 220x.
- Analysts expect its future annual earnings growth (25.0%) to be largely in line with prior year's earnings growth.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 51% over the next 5 years.
- In contrast, the Pharma industry is expected to see its earnings grow by 5.8% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| REG1V Revenio Group Oyj | €35.46 | 2.3% +€21.3m | -15.3% | PE43.3x | |
| OPTOMED Optomed Oyj | €3.95 | 8.7% +€5.1m | -32.2% | PS4.3x | |
| AIFORIA Aiforia Technologies Oyj | €4.06 | 2.8% +€2.8m | -12.6% | PS56.3x | |
| BRETEC Bioretec Oy | €2.40 | 2.1% +€705.6k | 4.8% | n/a |